Showing results (51-60 of 557) with videos related to
Sort By:
Pageof 56
Mineral and Electrolyte Metabolism|January 1, 1991
Current advances in the therapy of secondary hyperparathyroidism and osteitis fibrosaF Llach, B NikakhtarAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 2, 2001
Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidismF Llach, M YuddDrug Safety|January 5, 2002
Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studiesP WeidmannSchweizerische Medizinische Wochenschrift|November 15, 1986
[Hypertension management in practice, 1986]P WeidmannInternational Journal of Obesity|January 1, 1981
Pressor factors and cardiovascular pressor reponsiveness in essential hypertensionP WeidmannSchweizerische Medizinische Wochenschrift|July 12, 1983
[Long-term treatment of hypertension in 1983]P WeidmannSchweizerische Medizinische Wochenschrift|May 2, 1981
[New blood pressure-reducing medication]P WeidmannClinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1989
Pathogenetic and therapeutic relevance of cardiovascular pressor reactivity to norepinephrine in human hypertensionP WeidmannKlinische Wochenschrift|October 1, 1980
Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitusP WeidmannKidney International|April 1, 1993
Parathyroid gland function in chronic renal failureA J Felsenfeld, F LlachPageof 56